PharmaZell is a newly established company that has taken over Noveon s business of active pharmaceutical ingredients (APIs) and intermediates in May 2006. This management buy-out enables PharmaZell to become entirely focused on the pharmaceutical industry. In June 2007 Pharmazell acquired from Sandoz a controlling stake in GEA Pharmaceutical located in Copenhagen, Denmark. GEA s broad capabilities in finished dosage form development and the experience in controlled substances complement now the portfolio of services and products that Pharmazell offers to its customers.

Acquired Companies: GEA Pharmaceutical A/S